TACTIVA THERAPEUTICS
Tactiva Therapeutics is an Immuno-Oncology Company Utilizing an Innovative Approach to Adoptive Cell Therapy.
TACTIVA THERAPEUTICS
Social Links:
Industry:
Biotechnology Oncology
Founded:
2016-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.tactivatherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Euro Google Font API Google Analytics HSTS WordPress
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Vittoria Biotherapeutics
Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Founder
Investors List
Panacea Venture
Panacea Venture investment in Series A - Tactiva Therapeutics
Viventures
Viventures investment in Series A - Tactiva Therapeutics
EFung Capital
EFung Capital investment in Series A - Tactiva Therapeutics
Official Site Inspections
http://www.tactivatherapeutics.com Semrush global rank: 13.34 M Semrush visits lastest month: 78
- Host name: 152.0.153.160.host.secureserver.net
- IP address: 160.153.0.152
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Tactiva Therapeutics"
Tactiva Therapeutics - Crunchbase Company Profile & Funding
Tactiva Therapeutics is a development stage immuno-oncology company. View contacts for Tactiva Therapeutics to access new leads and connect with decision-makers.See details»
Tactiva Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Tactiva Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
About Us - Tactiva Therapeutics
Jay Zhang, PhD, has large experience in Executive roles in Biopharma. Dr. Zhang is the co-founder & CEO of TriArm Therapeutics, and is a Venture Partner of Panacea Venture.See details»
Tactiva Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Tactiva Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Tactiva Therapeutics Company Overview, Contact Details
Dec 2, 2024 Tactiva Therapeutics LLC launched novel autologous cellular immunotherapy on May 15th '17. Tactiva Therapeutics, a development stage company targeting a broad range of …See details»
Tactiva Therapeutics Company Profile - Craft
Tactiva Therapeutics has 5 employees across 2 locations and $35 m in total funding,. See insights on Tactiva Therapeutics including office locations, competitors, revenue, financials, …See details»
Tactiva Therapeutics
BUFFALO, N.Y.(WKBW) – Lieutenant Governor Kathy Hochul, Dr. Candace Johnson and a special team of doctors at Roswell Park announced the launch of a new innovative …See details»
Tactiva Therapeutics - VentureRadar
Tactiva is a development stage immuno-oncology company with a unique approach to adoptive T-cell therapy. Tactiva's dual enhanced adoptive cell... ... Find out more ...See details»
Tactiva Therapeutics - Company Profile - Tracxn
Feb 1, 2025 Email ID: *****@tactivatherapeutics.com; Phone Number: +1 ***** Key Metrics. Total Funding. $35M in 1 round. Latest Funding Round. Series A, Dec 03, 2018, $35M. …See details»
Tactiva Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Tactiva Therapeutics, Inc. of Buffalo, NY. Get the latest business insights from Dun & Bradstreet.See details»
Tactiva Therapeutics Overview | SignalHire Company Profile
Organization Website: tactivatherapeutics.com : Tactiva Therapeutics industries Biotech: Headquarters Location: 701 Ellicott St, Buffalo, New York, 14203 US 701 Ellicott St, Buffalo, …See details»
Tactiva Therapeutics Company Profile -Sales, Contacts, …
Tactiva Therapeutics is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»
Tactiva Therapeutics - LinkedIn
Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor approach.See details»
Tactiva Therapeutics - Overview, News & Similar companies
Dec 2, 2018 Tactiva Therapeutics contact info: Phone number: (716) 536-2971 Website: www.tactivatherapeutics.com What does Tactiva Therapeutics do? Tactiva is a development …See details»
Tactiva Therapeutics Company Information - Funding, Investors, …
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Tactiva Therapeutics Co-Founder Kunle Odunsi Elected to National ...
The National Academy of Medicine, established in 1970 as the Institute of Medicine, is an independent organization of eminent professionals from diverse fields including health and …See details»
Tactiva Therapeutics Co-Founder Kunle Odunsi Elected to
Oct 18, 2018 BUFFALO, N.Y., /PRNewswire/ -- Tactiva Therapeutics, a development stage company targeting a broad range of cancers, announced today that its co-founder Kunle …See details»
Teva and Sanofi Present New Positive Phase 2b Study Results at …
Feb 22, 2025 During the conference call, Eric Hughes, MD, PhD, Executive Vice President of Global R&D and Chief Medical Officer, and external IBD key opinion leaders (KOLs) will …See details»
Tactiva Therapeutics Secures $35 Million Series A Financing to …
Abstract Buffalo, NY, December 3, 2018 – Tactiva Therapeutics, development stage immuno-oncology company with a unique approach to adoptive T-cell therapy, announced today it has …See details»
The Science Behind Adoptive - Tactiva Therapeutics
A combination of a unique class of lethal CD4-TCRs derived from hematopoietic stem cells (HSCs) and mature CD8-TCRs targeting solid tumors expressing NY-ESO-1 – NY-ESO-1 is …See details»